<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="52396">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02424071</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-2015-1841-HB-CTIL</org_study_id>
    <nct_id>NCT02424071</nct_id>
  </id_info>
  <brief_title>The Effect of Premedication With Melatonin on Postoperative Recovery From Bariatric Surgery</brief_title>
  <official_title>The Effect of Premedication With Melatonin on Postoperative Recovery From Bariatric Surgery: a Prospective Randomised Controlled Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Melatonin has sedative, hypnotic, analgesic, antiinflammatory, and chronobiologic properties
      that make it a good premedication agent before anesthesia and surgery. Patients undergoing
      surgery in our establishment usually receive benzodiazepines as premedicants to reduce
      anxiety before the surgery. For bariatric patients benzodiazepines are usually avoided due
      to side effects which could be deleterious in obese patients.

      In this study the investigators intend to randomise 60 patients undergoing bariatric surgery
      into two groups. The participants will receive either melatonin or placebo on the evening
      prior to the surgery, and the same agent two hours before the surgery.

      The patients recovery from the surgery and anesthesia will be assessed using the Q0R15
      questionnaire. The patients will be asked to take the questionnaire once in the
      pre-operative clinic, again after the second melatonin or placebo pill before entering the
      operating room, and once more on the first post-operative day.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of recovery after surgery</measure>
    <time_frame>First post operative day</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Recovery From Bariatric Surgery</condition>
  <arm_group>
    <arm_group_label>Melatonin group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive a pill containing 5mg of melatonin on the evening before the surgery. Patients will receive another pill containing 5mg of melatonin two hours prior to surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will receive a pill containing placebo on the evening before the surgery. Patients will receive another pill containing placebo two hours prior to surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Melatonin</intervention_name>
    <arm_group_label>Melatonin group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing bariatric surgery

        Exclusion Criteria:

          -  Known allergy to melatonin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Haim Berkenstadt, MD</last_name>
    <phone>97235302966</phone>
    <email>Haim.Berkenstadt@sheba.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michal Ivry, MD</last_name>
    <phone>97235302966</phone>
    <email>mwirguin@yahoo.com</email>
  </overall_contact_backup>
  <link>
    <url>http://ods.od.nih.gov/factsheets/list-all/</url>
    <description>Melatonin NIH fact sheet</description>
  </link>
  <reference>
    <citation>Yousaf F, Seet E, Venkatraghavan L, Abrishami A, Chung F. Efficacy and safety of melatonin as an anxiolytic and analgesic in the perioperative period: a qualitative systematic review of randomized trials. Anesthesiology. 2010 Oct;113(4):968-76. doi: 10.1097/ALN.0b013e3181e7d626. Review.</citation>
    <PMID>20823763</PMID>
  </reference>
  <reference>
    <citation>Caumo W, Torres F, Moreira NL Jr, Auzani JA, Monteiro CA, Londero G, Ribeiro DF, Hidalgo MP. The clinical impact of preoperative melatonin on postoperative outcomes in patients undergoing abdominal hysterectomy. Anesth Analg. 2007 Nov;105(5):1263-71, table of contents.</citation>
    <PMID>17959953</PMID>
  </reference>
  <reference>
    <citation>Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess. 1998;2(14):i-iv, 1-74. Review.</citation>
    <PMID>9812244</PMID>
  </reference>
  <reference>
    <citation>Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013 Jun;118(6):1332-40. doi: 10.1097/ALN.0b013e318289b84b.</citation>
    <PMID>23411725</PMID>
  </reference>
  <verification_date>April 2015</verification_date>
  <lastchanged_date>April 21, 2015</lastchanged_date>
  <firstreceived_date>April 19, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Haim Berkenstadt</investigator_full_name>
    <investigator_title>Director of Anesthesia, Sheba medical center</investigator_title>
  </responsible_party>
  <keyword>melatonin's</keyword>
  <keyword>quality of recovery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Melatonin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
